Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$69.28 - $93.38 $671,600 - $905,225
9,694 Added 7.12%
145,778 $10.1 Million
Q2 2023

Aug 04, 2023

SELL
$81.41 - $94.33 $112,752 - $130,647
-1,385 Reduced 1.01%
136,084 $12.8 Million
Q1 2023

May 09, 2023

SELL
$74.26 - $84.51 $710,222 - $808,253
-9,564 Reduced 6.5%
137,469 $11.4 Million
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $1.48 Million - $1.9 Million
21,702 Added 17.32%
147,033 $11 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $118,942 - $154,926
1,444 Added 1.17%
125,331 $10.4 Million
Q2 2022

Aug 08, 2022

BUY
$86.5 - $128.27 $112,450 - $166,751
1,300 Added 1.06%
123,887 $11.8 Million
Q1 2022

May 12, 2022

SELL
$101.96 - $128.34 $1.09 Million - $1.37 Million
-10,696 Reduced 8.03%
122,587 $14.9 Million
Q4 2021

Feb 15, 2022

BUY
$106.37 - $130.68 $11.3 Million - $13.8 Million
105,790 Added 384.79%
133,283 $17.4 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $227,739 - $271,645
2,213 Added 8.75%
27,493 $3.12 Million
Q2 2021

Aug 06, 2021

SELL
$83.84 - $104.76 $277,258 - $346,441
-3,307 Reduced 11.57%
25,280 $2.62 Million
Q1 2021

May 13, 2021

SELL
$78.68 - $90.67 $78,286 - $90,216
-995 Reduced 3.36%
28,587 $2.39 Million
Q4 2020

Feb 12, 2021

SELL
$71.69 - $91.23 $159,151 - $202,530
-2,220 Reduced 6.98%
29,582 $2.7 Million
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $169,050 - $219,999
2,516 Added 8.59%
31,802 $2.54 Million
Q2 2020

Aug 12, 2020

BUY
$57.54 - $76.95 $260,195 - $347,967
4,522 Added 18.26%
29,286 $2.02 Million
Q1 2020

May 13, 2020

BUY
$52.41 - $81.0 $373,106 - $576,639
7,119 Added 40.35%
24,764 $4.67 Million
Q4 2019

Feb 13, 2020

BUY
$71.7 - $82.09 $1.27 Million - $1.45 Million
17,645 New
17,645 $4.12 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Banco Bilbao Vizcaya Argentaria, S.A. Portfolio

Follow Banco Bilbao Vizcaya Argentaria, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.